Novo Holdings, the controlling shareholder of Novo Nordisk, hopes to double the size of its recently acquired contract ...

Novavax NVAX announced that it has agreed to sell its manufacturing facility ... sale opportunities for the plant to save operating costs. If the deal with Novo Nordisk goes through, the company ...

Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans to spend around DKK 8.5 billion ($1.2 billion) on the plant.

The new plant will be one of the largest manufacturing investments in Novo Nordisk’s history and will add 1.4 million sq ft of production space for aseptic manufacturing and finished production ...

It will boost the manufacturing capability for its ... dynamic community and talented workforce,” he added. Novo Nordisk also plans to plant 4,000 new trees at the site in an effort to preserve ...

Novo Holdings plans to double its newly acquired contract drugmaker, Catalent, within five years, focusing on U.S. manufacturing. The $16.5 billion acquisition is aimed at enhancing supply chains amid ...

“This will provide the local plant with growing demand ... and insights into fill/finish manufacturing and will play a key role in Novo Nordisk’s aim to serve even more patients,” said ...

While the recent launches of GLP-1 drugs from Novo Nordisk and Eli ... pharmaceutical ingredients plant in Lebanon, Indiana, to plans for a $4.5 billion R&D and manufacturing facility—also ...

Eli Lilly, a competitor in the market for GLP-1 weight loss drugs, was up about 5%. Novo Nordisk's stock suffered its biggest one-day slide on record after its latest obesity drug trial ...

EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 ... 2024 One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years ...